Primary gastric lymphoma pathogenesis and treatment: What has changed over the past 10 years?

British Journal of Haematology

Volumn 136, Issue 4, 2007, Pages 521-538

  Ferrucci, Pier Francesco ^a   Zucca, Emanuele ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b REGIONAL HOSPITAL OF LUGANO   (Switzerland)

Author keywords

Extra nodal lymphomas; Helicobacter pylori infection; Mucosa associated lymphoid tissue lymphomas; Primary gastric lymphomas

Indexed keywords

ANTIBIOTIC AGENT; BLEOMYCIN; BORTEZOMIB; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IBRITUMOMAB TIUXETAN; METHOTREXATE; MITOXANTRONE; PREDNISONE; PROTON PUMP INHIBITOR; RITUXIMAB; VINCRISTINE; VINCRISTINE SULFATE;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL PROTOCOL; CLINICAL TRIAL; FOLLICULAR LYMPHOMA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LARGE CELL LYMPHOMA; MANTLE CELL LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; REVIEW; STOMACH LYMPHOMA;

HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; LYMPHOMA, NON-HODGKIN; STOMACH NEOPLASMS;

EID: 33846454674     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06444.x     Document Type: Review

References (142)

1. d'Amore, F., Christensen, B.E., Brincker, H., Pedersen, N.T., Thorling, K., Hastrup, J., Pedersen, M., Jensen, M.K., Johansen, P., Andersen, E., Bach, B. & Sorensen, E. (1991) Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. European Journal of Cancer, 27, 1201-1208.
2. Ahmed, N. & Sechi, L.A. (2005) Helicobacter pylori and gastroduodenal pathology: new threats of the old friend. Annals of Clinical Microbiology and Antimicrobials, 5, 1.
3. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, Jr, J., Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R. & Staudt, L.M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503-511.
4. Ambrosini, V., Rubello, D., Castellucci, P., Nanni, C., Farsad, M., Zinzani, P., Alavi, A., Tenranipour, N., Al-Nahhas, A. & Fanti, S. (2006) Diagnostic role of 18F-FDG PET in gastric MALT lymphoma. Nuclear Medical Review of Central East Europe, 9, 37-40.
5. Aviles, A., Nambo, M.J., Neri, N., Huerta-Guzman, J., Cuadra, I., Alvarado, I., Castaneda, C., Fernandez, R. & Gonzalez, M. (2004) The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Annals of Surgery, 240, 44-50.
6. Bayerdorffer, E., Neubauer, A., Rudolph, B., Thiede, C., Lehn, N., Eidt, S. & Stolte, M. (1995) Regression of primary gastric lymphoma of mu-cosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet, 345, 1591-1594.
7. Beal, K.P., Yeung, H.W. & Yahalom, J. (2005) FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Annals of Oncology, 16, 473-480.
8. Bertoni, F. & Zucca, E. (2005) State-of-the-art therapeutics: marginalzone lymphoma. Journal of Clinical Oncology, 23, 6415-6420.
9. Bertoni, F., Cazzaniga, G., Bosshard, G., Roggero, E., Barbazza, R., De Boni, M., Capella, C., Pedrinis, E., Cavalli, F., Biondi, A. & Zucca, E. (1997) Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process. British Journal of Haematology, 97, 830-836.
10. Bertoni, F., Sanna, P., Tinguely, M., Roggero, E., Conconi, A., Gisi, M., Cazzaniga, G., Biondi, A., Pedrinis, E., Cavalli, F. & Zucca, E. (2000) Association of gastric and Waldeyer's ring lymphoma: a molecular study. Hematological Oncology, 18, 15-19.
11. Bertoni, F., Conconi, A., Capella, C., Motta, T., Giardini, R., Ponzoni, M., Pedrinis, E., Novero, D., Rinaldi, P., Cazzaniga, G., Biondi, A., Wotherspoon, A., Hancock, B.W., Smith, P., Souhami, R., Cotter, F.E., Cavalli, F. & Zucca, E. (2002) Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood, 99, 2541-2544.
12. Caletti, G., Zinzani, P.L., Fusaroli, P., Buscarini, E., Parente, F., Federici, T., Peyre, S., De Angelis, C., Bonanno, G., Togliani, T., Pileri, S. & Tura, S. (2002) The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma. Alimentary Pharmacololgy & Therapeutics, 16, 1715-1722.
13. Cavalli, F., Isaacson, P.G., Gascoyne, R.D. & Zucca, E. (2001) MALT Lymphomas. Hematology (American Society of Hematology, Education Program), 241-258.
14. Chen, L.T., Lin, J.T., Tai, J.J., Chen, G.H., Yeh, H.Z., Yang, S.S., Wang, H.P., Kuo, S.H., Sheu, B.S., Jan, C.M., Wang, W.M., Wang, T.E., Wu, C.W., Chen, C.L., Su, I.J., Whang-Peng, J. & Cheng, A.L. (2005) Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. Journal of the National Cancer Institute, 97, 1345-1353.
15. Chen, Y.W., Hu, X.T., Liang, A.C., Au, W.Y., So, C.C., Wong, M.L., Shen, L., Tao, Q., Chu, K.M., Kwong, Y.L., Liang, R.H. & Srivastava, G. (2006) High BCL-6 expression predicts better prognosis, independent of BCL-6 translocation status, translocation partner or BCL-6 deregulating mutations, in gastric lymphoma. Blood, 108, 2373-2383.
16. Cheson, B.D. (2003) Radioimmunotherapy of non-Hodgkin lymphomas. Blood, 101, 391-491.
17. Chiu, B.C. & Weisenburger, D.D. (2003) An update of the epidemiology of non-Hodgkin's lymphoma. Clinical Lymphoma, 4, 161-168.
18. Cogliatti, S.B., Schmid, U., Schumacher, U., Eckert, F., Hansmann, M.L., Hedderich, J., Takahashi, H. & Lennert, K. (1991) Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology, 101, 1159-1170.
19. Cogliatti, S.B., Griesser, H., Peng, H., Du, M.Q., Isaacson, P.G., Zimmermann, D.R., Maibach, R.C. & Schmid, U. (2000) Significantly different BCL-2 expression profiles in gastric and nongastric primary extranodal high-grade B-cell Lymphomas. Journal of Pathology, 192, 470-478.
20. Coia, L.R., Myerson, R.J. & Tepper, J.E. (1995) Late effects of radiation therapy on the gastrointestinal tract. International Journal of Radiation Oncology, Biology, Physics, 31, 1213-1236.
21. Coiffier, B. & Salles, G. (1997) Does surgery belong to medical history for gastric lymphomas? Annals of Oncology, 8, 419-421.
22. Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F., Lederlin, P. & Gisselbrecht, C. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. New England Journal of Medicine, 346, 235-242.
23. Conconi, A., Martinelli, G., Thieblemont, C., Ferreri, A.J., Devizzi, L., Peccatori, F., Ponzoni, M., Pedrinis, E., Dell'Oro, S., Pruneri, G., Filipazzi, V., Dietrich, P.Y., Gianni, A.M., Coiffier, B., Cavalli, F. & Zucca, E. (2003) Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood, 102, 2741-2745.
24. Copie-Bergman, C., Gaulard, P., Lavergne-Slove, A., Brousse, N., Flejou, J.F., Dordonne, K., de Mascarel, A. & Wotherspoon, A.C. (2003) Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut, 52, 1656.
25. Copie-Bergman, C., Capella, C., Motta, T., Pedrinis, E., Pileri, A., Ponzoni, M., Bertoni, F., Conconi, A., Zucca, E. & Wotherspoon, A. (2005) Validation of the GELA scoring system for evaluating gastric biopsies from patients with malt lymphoma following eradication of Helicobacter pylori' (abstract 194). Annals of Oncology, 16 (Suppl. 5), 94.
26. Dawson, I.M., Cornes, J.S. & Morson, B.C. (1961) Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. British Journal of Surgery, 49, 80-89.
27. Devesa, S.S. & Fears, T. (1992) Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Research, 52, 5432s-5440s.
28. Dogan, A., Du, M., Koulis, A., Briskin, M.J. & Isaacson, P.G. (1997) Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. American Journal of Pathology, 151, 1361-1369.
29. Doglioni, C., Wotherspoon, A.C., Moschini, A., De Boni, M. & Isaacson, P.G. (1992) High incidence of primary gastric lymphoma in northeastern Italy. Lancet, 339, 834-835.
30. van Doorn, N.E., Namavar, F., van Doorn, L.J., Durrani, Z., Kuipers, E.J. & Vandenbroucke-Grauls, C.M. (1999) Analysis of vacA, cagA, and IS605 genotypes and those determined by PCR amplification of DNA between repetitive sequences of Helicobacter pylori strains isolated from patients with nonulcer dyspepsia or mucosa-associated lymphoid tissue lymphoma. Journal of Clinical Microbiology, 37, 2348-2349.
31. Drillenburg, P. & Pals, S.T. (2000) Cell adhesion receptors in lymphoma dissemination. Blood, 95, 1900-1910.
32. Drillenburg, P., van der Voort, R., Koopman, G., Dragosics, B., van Krieken, J.H., Kluin, P., Meenan, J., Lazarovits, A.I., Radaszkiewicz, T. & Pals, S.T. (1997) Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas. American Journal of Pathology, 150, 919-927.
33. Eck, M., Schmausser, B., Haas, R., Greiner, A., Czub, S. & Muller-Hermelink, H.K. (1997) MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology, 112, 1482-1486.
34. Eidt, S., Stolte, M. & Fischer, R. (1994) Factors influencing lymph node infiltration in primary gastric malignant lymphoma of the mucosa-associated lymphoid tissue. Pathology Research and Practice, 190, 1077-1081.
35. Elstrom, R., Guan, L., Baker, G., Nakhoda, K., Vergilio, J.A., Zhuang, H., Pitsilos, S., Bagg, A., Downs, L., Mehrotra, A., Kim, S., Alavi, A. & Schuster, S.J. (2003) Utility of FDG-PET scanning in lymphoma by WHO classification. Blood, 101, 3875-3876.
36. Ferreri, A.J., Cordio, S., Ponzoni, M. & Villa, E. (1999) Non-surgical treatment with primary chemotherapy, with or without radiation therapy, of stage I-II high-grade gastric lymphoma. Leukemia and Lymphoma, 33, 531-541.
37. 90y ibritumomab-tiuxetan treatment in resistant gastric MALT non Hodgkin's lymphoma. ASH Proceedings, Blood, 108, 2771 (abstract).
38. Fischbach, W., Kestel, W., Kirchner, T., Mossner, J. & Wilms, K. (1992) Malignant lymphomas of the upper gastrointestinal tract. Results of a prospective study in 103 patients. Cancer, 70, 1075-1080.
39. Fischbach, W., Goebeler-Kolve, M.E. & Greiner, A. (2002) Diagnostic accuracy of EUS in the local staging of primary gastric lymphoma: results of a prospective, multicenter study comparing EUS with histopathologic stage. Gastrointestinal Endoscopy, 56, 696-700.
40. Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Glick, J.H., Coltman, Jr, C.A. & Miller, T.P. (1993) Comparison of a standard regimen (CHOP) with three intensive chemiotherapy regimens for advance non Hodgkin's lymphoma. New England Journal of Medicine, 328, 1002-1006.
41. Fusaroli, P., Buscarini, E., Peyre, S., Federici, T., Parente, F., De Angelis, C., Bonanno, G., Meroni, E., Napolitano, V., Pisani, A., Sottili, S., Togliani, T. & Caletti, G. (2002) Interobserver agreement in staging gastric MALT lymphoma by EUS. Gastrointestinal Endoscopy, 55, 662-668.
42. Gobbi, P.G., Dionigi, P., Barbieri, F., Corbella, F., Bertoloni, D., Grignani, G., Jemos, V., Pieresca, C. & Ascari, E. (1990) The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature. Cancer, 65, 2528-2536.
43. Gobbi, P.G., Ghirardelli, M.L., Cavalli, C., Baldini, L., Broglia, C., Clo, V., Berte, R., Ilariucci, F., Carotenuto, M., Piccinini, L., Stelitano, C., Attardo-Parrinello, G. & Ascari, E. (2000) The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas. Haematologica, 85, 372-380.
44. Gospodarowicz, M. & Tsang, R. (2004) Radiation therapy of mucosa-associated lymphoid tissue (MALT) lymphomas'. In: MALT Lymphomas, Landes Bioscience/Kluwer Academic (ed. by E. Zucca), pp. 104-129. Georgetown, Texas.
45. Groves, F.D., Linet, M.S., Travis, L.B. & Devesa, S.S. (2000) Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. Journal of the National Cancer Institute, 92, 1240-1251.
46. Gurney, K.A. & Cartwright, R.A. (2002) Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Hematology Journal, 3, 95-104.
47. Gurney, K.A., Cartwright, R.A. & Gilman, E.A. (1999) Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry. British Journal of Cancer, 79, 1929-1934.
48. Hammel, P., Haioun, C., Chaumette, M.T., Gaulard, P., Divine, M., Reyes, F. & Delchier, J.C. (1995) Efficacy of single-agent chemotherapy in low-grade B-cell mucosa- associated lymphoid tissue lymphoma with prominent gastric expression. Journal of Clinical Oncology, 13, 2524-2529.
49. Hancock, B., Linch, D., Delchier, J., Qian, W., Smith, P., Wotherspoon, A., Copie-Bergman, C., Traulle, C., Cortelazzo, S., Ferreri, A.J., Ambrosetti, A., Pinotti, G., Cavalli, F., Souhami, R. & Zucca, E. (2005) Chlorambucil versus observation after anti-Helicobacter therapy in low-grade gastric lymphoma: results of the international LY03 trial' (abstract 74). Annals of Oncology, 16(Suppl. 5), 57.
50. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
51. Hayes, J. & Dunn, E. (1989) Has the incidence of primary gastric lymphoma increased? Cancer, 63, 2073-2076.
52. Herrmann, R., Panahon, A.M., Barcos, M.P., Walsh, D. & Stutzman, L. (1980) Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer, 46, 215-222.
53. Hockey, M.S., Powell, J., Crocker, J. & Fielding, J.W. (1987) Primary gastric lymphoma. British Journal of Surgery, 74, 483-487.
54. Hoffmann, M., Kletter, K., Diemling, M., Becherer, A., Pfeffel, F., Petkov, V., Chott, A. & Raderer, M. (1999) Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type. Annals of Oncology, 10, 1185-1189.
55. Howden, C.W. & Hunt, R.H. (1998) Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. American Journal of Gastroenterology, 93, 2330-2338.
56. Hussell, T., Isaacson, P.G., Crabtree, J.E. & Spencer, J. (1993) The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet, 342, 571-574.
57. Hussell, T., Isaacson, P.G., Crabtree, J.E. & Spencer, J. (1996) Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Journal of Pathology, 178, 122-127.
58. Isaacson, P.G. (1995) The MALT lymphoma concept updated. Annals of Oncology, 6, 319-320.
59. Isaacson, P.G. & Du, M.Q. (2004) MALT lymphoma: from morphology to molecules. Nature Reviews Cancer, 4, 644-653.
60. Isaacson, P.G., Diss, T.C., Wotherspoon, A.C., Barbazza, R., De Boni, M. & Doglioni, C. (1999) Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies. Gastroenterology, 117, 750-751.
61. Isaacson, P.G., Muller-Hermelink, H.K., Piris, M.A., Berger, F., Nathwani, B.N., Swerdlow, S. & Harris, N.L. (2001) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: World Health Organization Classification of Tumours (eds by E.S. Jaffe, N.L. Harris, H. Stein & J.W. Vardiman), pp. 157-160. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, France.
62. Jaffe, E.S., Harris, N.L., Stein, H., Vardiman, J.W., eds (2001) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, France.
63. Jager, G., Neumeister, P., Brezinschek, R., Hinterleitner, T., Fiebiger, W., Penz, M., Neumann, H.J., Mlineritsch, B., DeSantis, M., Quehenberger, F., Chott, A., Beham-Schmid, C., Hofler, G., Linkesch, W. & Raderer, M. (2002) Treatment of extranodal marginal zone B-Cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: A phase II study. Journal of Clinical Oncology, 20, 3872-3877.
64. Jager, G., Hofler, G., Linkesch, W. & Neumeister, P. (2004) Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chlorodeoxyadenosine (2- CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature. Haematologica, 89, ECR01.
65. Jager, G., Neumeister, P., Quehenberger, F., Wohrer, S., Linkesch, W. & Raderer, M. (2006) Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial. Annals of Oncology, doi: 10.1093/annonc/mdl126.
66. de Jong, D., van der Hulst, R.W., Pals, G. van Dijk, W.C., van der Ende, A., Tytgat, G.N., Taal, B.G. & Boot, H. (1996) Gastric non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA. American Journal of Clinical Pathology, 106, 670-675.
67. de Jong, D., Boot, H., van Heerde, P., Hart, G.A. & Taal, B.G. (1997) Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology, 112, 1466-1474.
68. Koch, P., del Valle, F., Berdel, W.E., Willich, N.A., Reers, B., Hiddemann, W., Grothaus-Pinke, B., Reinartz, G., Brockmann, J., Temmesfeld, A., Schmitz, R., Rube, C., Probst, A., Jaenke, G., Bodenstein, H., Junker, A., Pott, C., Schultze, J., Heinecke, A., Parwaresch, R., Tiemann, M. (2001a) Primary gastrointestinal non-Hodgkin's lymphoma: anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German multicenter study GIT NHL 01/92. Journal of Clinical Oncology, 19, 3861-3873.
69. Koch, P., del Valle, F., Berdel, W.E., Willich, N.A., Reers, B., Hiddemann, W., Grothaus-Pinke, B., Reinartz, G., Brockmann, J., Temmesfeld, A., Schmitz, R., Rube, C., Probst, A., Jaenke, G., Bodenstein, H., Junker, A., Pott, C., Schultze, J., Heinecke, A., Parwaresch, R. & Tiemann, M. (2001b) Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma - results of the prospective German Multicenter Study GIT NHL 01/92. Journal of Clinical Oncology, 19, 3874-3883.
70. Koch, P., Probst, A., Berdel, W.E., Willich, N.A., Reinartz, G., Brockmann, J., Liersch, R., Del Valle, F., Clasen, H., Hirt, C., Breitsprecher, R., Schmits, R., Freund, M., Fietkau, R., Ketterer, P., Freitag, E.M., Hinkelbein, M., Heinecke, A., Parwaresch, R. & Tiemann, M. (2005) Treatment results in localized primary gastric lymphoma: data of patients registered within the German Multicenter Study (GIT NHL 02/96). Journal of Clinical Oncology, 23, 7050-7059.
71. Koga, H., Sasaki, M., Kuwabara, Y., Hiraka, K., Nakagawa, M., Abe, K., Kaneko, K., Hayashi, K. & Honda, H. (2003) An analysis of the physiological FDG uptake pattern in the stomach. Annals of Nuclear Medicine, 17, 733-738.
72. Kumar, R., Xiu, Y., Potenta, S., Mavi, A., Zhuang, H., Yu, J.Q., Dhuarairaj, T., Dadparvar, S. & Alavi, A. (2004) 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. Journal of Nuclear Medicine, 45, 1796-1803.
73. Levy, M., Copie-Bergman, C., Traulle, C., Lavergne-Slove, A., Brousse, N., Flejou, J.F., de Mascarel, A., Hemery, F., Gaulard, P. & Delchier, J.C. (2002) Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. American Journal of Gastroenterology, 97, 292-297.
74. Lewin, K.J., Ranchod, M. & Dorfman, R.F. (1978) Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer, 42, 693-707.
75. Liu, H., Ruskon-Fourmestraux, A., Lavergne-Slove, A., Ye, H., Molina, T., Bouhnik, Y., Hamoudi, R.A., Diss, T.C., Dogan, A., Megraud, F., Rambaud, J.C., Du, M.Q. & Isaacson, P.G. (2001a) Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet, 357, 39-40.
76. Liu, H., Ye, H., Dogan, A., Ranaldi, R., Hamoudi, R.A., Bearzi, I., Isaacson, P.G. & Du, M.Q. (2001b) T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood, 98, 1182-1187.
77. Liu, H., Ye, H., Ruskone-Fourmestraux, A., De Jong, D., Pileri, S., Thiede, C., Lavergne, A., Boot, H., Caletti, G., Wundisch, T., Molina, T., Taal, B.G., Elena, S., Thomas, T., Zinzani, P.L., Neubauer, A., Stolte, M., Hamoudi, R.A., Dogan, A., Isaacson, P.G. & Du, M.Q. (2002) T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology, 122, 1286-1294.
78. Malfertheiner, P., Megraud, F., O'Morain, C., Bell, D., Bianchi Porro, G., Deltenre, M., Forman, D., Gasbarrini, G., Jaup, B., Misiewicz, J.J., Pajares, J., Quina, M. & Rauws, E. (1997) Current European concepts in the management of Helicobacter pylori infection - The Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). European Journal of Gastroenterology & Hepatology, 9, 1-2.
79. Maor, M.H., Velasquez, W.S., Fuller, L.M. & Silvermintz, K.B. (1990) Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma. Journal of Clinical Oncology, 8, 266-271.
80. Martinelli, G., Laszlo, D., Ferreri, A.J., Pruneri, G., Ponzoni, M., Conconi, A., Crosta, C., Pedrinis, E., Bertoni, F., Calabrese, L. & Zucca, E. (2005) Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. Journal of Clinical Oncology, 23, 1979-1983.
81. Moller, M.B., Pedersen, N.T. & Christensen, B.E. (2004) Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation - a population-based study of 1575 cases. British Journal of Haematology, 124, 151-159.
82. Montalban, C., Santon, A., Boixeda, D. & Bellas, C. (2001) Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication. Gut, 49, 584-587.
83. Morgner, A., Miehlke, S., Fischbach, W., Schmitt, W., Muller-Hermelink, H., Greiner, A., Thiede, C., Schetelig, J., Neubauer, A., Stolte, M., Ehninger, G. & Bayerdorffer, E. (2001) Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. Journal of Clinical Oncology, 19, 2041-2048.
84. Morschhauser, F., Huglo, D., Martinelli, G., Paganelli, G., Zinzani, P.L., Hadjiyiannakis, D., Liberati, A., Illidge, T., Milpied, N., Stein, H., Kalmus, J., Morel, P., Reimann, U. & Marcus, R. (2004) Yttrium-90 Ibritumomab Tiuxetan (Zevalin) for patients with relapsed/refractory diffuse large B-cell lymphoma not appropriate for autologous stem cell transplantation: results of an open-label phase II trial. Blood (ASH Annual Meeting Abstracts), 104, Abst no. 130.
85. Musshoff, K. (1977) Clinical staging classification of non-Hodgkin's lymphoma. Strahlentherapie, 153, 218-221.
86. Nakamura, S., Yao, T., Aoyagi, K., Iida, M., Fujishima, M. & Tsuneyoshi, M. (1997) Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer, 79, 3-11.
87. Nakamura, S., Matsumoto, T., Suekane, H., Takeshita, M., Hizawa, K., Kawasaki, M., Yao, T., Tsuneyoshi, M., Iida, M. & Fujishima, M. (2001) Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut, 48, 454-460.
88. Neubauer, A., Thiede, C., Morgner, A., Alpen, B., Ritter, M., Neubauer, B., Wundisch, T., Ehninger, G., Stolte, M. & Bayerdorffer, E. (1997) Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. Journal of the National Cancer Institute, 89, 1350-1355.
89. O'Connor, O.A., Wright, J., Moskowitz, C., Muzzy, J., MacGregor-Cortelli, B., Stubblefield, M., Straus, D., Portlock, C., Hamlin, P., Choi, E., Dumetrescu, O., Esseltine, D., Trehu, E., Adams, J., Schenkein, D. & Zelenetz, A.D. (2005) Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma. Journal of Clinical Oncology, 23, 676-684.
90. Offit, K., Lococo, F. & Louie, D.C. (1994) Rearrrangement of the bcl-6 gene as prognostic marker in diffuse large cell lymphoma. New England Journal of Medicine, 331, 74-80.
91. Parkin, D.M., Pisani, P. & Ferlay, J. (1999) Global cancer statistics. CA - A Cancer Journal for Clinicians, 49, p. 31; 33-64.
92. Parsonnet, J., Hansen, S., Rodriguez, L., Gelb, A.B., Warnke, R.A., Jellum, E., Orentreich, N., Vogelman, J.H. & Friedman, G.D. (1994) Helicobacter pylori infection and gastric lymphoma. New England Journal of Medicine, 330, 1267-1271.
93. Peng, H., Ranaldi, R., Diss, T.C., Isaacson, P.G., Bearzi, I. & Pan, L. (1998) High frequency of CagA+ Helicobacter pylori infection in high-grade gastric MALT B-cell lymphomas. Journal of Pathology, 185, 409-412.
94. Pinotti, G., Zucca, E., Roggero, E., Pascarella, A., Bertoni, F., Savio, A., Savio, E., Capella, C., Pedrinis, E., Saletti, P., Morandi, E., Santandrea, G. & Cavalli, F. (1997) Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leukemia & Lymphoma, 26, 527-537.
95. Popescu, R.A., Wotherspoon, A.C., Cunningham, D., Norman, A., Prendiville, J. & Hill, M.E. (1999) Surgery plus chemotherapy or chemotherapy alone for primary intermediate- and high-grade gastric non-Hodgkin's lymphoma: the Royal Marsden Hospital experience. European Journal of Cancer, 35, 928-934.
96. Radaszkiewicz, T., Dragosics, B. & Bauer, P. (1992) Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology, 102, 1628-1638.
97. Raderer, M., Valencak, J., Osterreicher, C., Drach, J., Hejna, M., Kornek, G., Scheithauer, W., Brodowicz, T., Chott, A. & Dragosics, B. (2000) Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIE. Cancer, 88, 1979-1985.
98. Raderer, M., Chott, A., Drach, J., Montalban, C., Dragosics, B., Jager, U., Puspok, A., Osterreicher, C. & Zielinski, C.C. (2002) Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary? Annals of Oncology, 13, 1094-1098.
99. Raderer, M., Wohrer, S., Bartsch, R., Prager, G., Drach, J., Hejna, M., Gaiger, A., Turetschek, K., Jaeger, U., Streubel, B. & Zielinski, C.C. (2005) Phase II study of Oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. Journal of Clinical Oncology, 23, 8442-8446.
100. Raderer, M., Streubel, B., Wohrer, S., Hafner, M. & Chott, A. (2006) Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut, 55, 616-618.
101. Roggero, E., Zucca, E., Pinotti, G., Pascarella, A., Capella, C., Savio, A., Pedrinis, E., Paterlini, A., Venco, A. & Cavalli, F. (1995) Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Annals of Internal Medicine, 122, 767-769.
102. Rohatiner, A., d'Amore, F., Coiffier, B., Crowther, D., Gospodarowicz, M., Isaacson, P., Lister, T.A., Norton, A., Salem, P. & Shipp, M. (1994) Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Annals of Oncology, 5, 397-400.
103. Rollinson, S., Levene, A.P., Mensah, F.K., Roddam, P.L., Allan, J.M., Diss, T.C., Roman, E., Jack, A., MacLennan, K., Dixon, M.F. & Morgan, G.J. (2003) Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood, 102, 1007-1011.
104. Ruskone-Fourmestraux, A., Lavergne, A., Aegerter, P.H., Megraud, F., Palazzo, L., de Mascarel, A., Molina, T. & Rambaud, J.L. (2001) Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut, 48, 297-303.
105. Ruskone-Fourmestraux, A., Dragosics, B., Morgner, A., Wotherspoon, A. & Dd Jong, D. (2003) Paris staging system for primary gastrointestinal lymphomas. Gut, 52, 912-913.
106. Sackmann, M., Morgner, A., Rudolph, B., Neubauer, A., Thiede, C., Schulz, H., Kraemer, W., Boersch, G., Rohde, P., Seifert, E., Stolte, M. & Bayerdoerffer, E. (1997) Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology, 113, 1087-1090.
107. Salles, G., Herbrecht, R., Tilly, H., Berger, F., Brousse, N., Gisselbrecht, C. & Coiffier, B. (1991) Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs. The American Journal of Medicine, 90, 77-84.
108. Sanchez-Izquierdo, D., Buchonnet, G., Siebert, R., Gascoyne, R.D., Climent, J., Karran, L., Marin, M., Blesa, D., Horsman, D., Rosenwald, A., Staudt, L.M., Albertson, D.G., Du, M.Q., Ye, H., Marynen, P., Garcia-Conde, J., Pinkel, D., Dyer, M.J. & Martinez-Climent, J.A. (2003) MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma. Blood, 101, 4539-4546.
109. Schechter, N.R., Portlock, C.S. & Yahalom, J. (1998) Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. Journal of Clinical Oncology, 16, 1916-1921.
110. Schmidt, W.P., Schmitz, N. & Sonnen, R. (2004) Conservative management of gastric lymphoma: the treatment option of choice. Leukemia & Lymphoma, 45, 1847-1852.
111. Severson, R.K. & Davis, S. (1990) Increasing incidence of primary gastric lymphoma. Cancer, 66, 1283-1287.
112. Starostik, P., Greiner, A., Schultz, A., Zettl, A., Peters, K., Rosenwald, A., Kolve, M. & Muller-Hermelink, H.K. (2000) Genetic aberrations common in gastric high-grade large B-cell lymphoma. Blood, 95, 1180-1187.
113. Starostik, P., Patzner, J., Greiner, A., Schwarz, S., Kalla, J., Ott, G. & Muller-Hermelink, H.K. (2002) Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood, 99, 3-9.
114. Steinbach, G., Ford, R., Glober, G., Sample, D., Hagemeister, F.B., Lynch, P.M., McLaughlin, P.W., Rodriguez, M.A., Romaguera, J.E., Sarris, A.H., Younes, A., Luthra, R., Manning, J.T., Johnson, C.M., Lahoti, S., Shen, Y., Lee, J.E., Winn, R.J., Genta, R.M., Graham, D.Y. & Cabanillas, F.F. (1999) Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Annals of Internal Medicine, 131, 88-95.
115. Streubel, B., Lamprecht, A., Dierlamm, J., Cerroni, L., Stolte, M., Ott, G., Raderer, M. & Chott, A. (2003) T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood, 101, 2335-2339.
116. Taal, B.G., Boot, H., van Heerde, P., de Jong, D., Hart, A.A. & Burgers, J.M. (1996) Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept. Gut, 39, 556-561.
117. Taupin, A., Occhialini, A., Ruskone-Fourmestraux, A., Delchier, J.C., Rambaud, J.C. & Megraud, F. (1999) Serum antibody responses to Helicobacter pylori and the cagA marker in patients with mucosa-associated lymphoid tissue lymphoma. Clinical and Diagnostic Laboratory Immunology, 6, 633-638.
118. Thieblemont, C. (2005) Clinical presentation and management of marginal zone lymphomas. Hematology (American Society of Hematology, Education Program), 307-313.
119. Thieblemont, C., Dumontet, C., Bouafia, F., Hequet, O., Arnaud, P., Espinouse, D., Felman, P., Berger, F., Salles, G. & Coiffier, B. (2003) Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976-2001. Leukemia & Lymphoma, 44, 257-262.
120. Thiede, C., Wundisch, T., Alpen, B., Neubauer, B., Morgner, A., Schmitz, M., Ehninger, G., Stolte, M., Bayerdorffer, E. & Neubauer, A. (2001) Persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. Journal of Clinical Oncology, 19, 1600-1609.
121. Tsang, R.W., Gospodarowicz, M.K., Pintilie, M., Wells, W., Hodgson, D.C., Sun, A., Crump, M. & Patterson, B.J. (2003) Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. Journal of Clinical Oncology, 21, 4157-4164.
122. Venizelos, I., Tamiolakis, D., Bolioti, S., Nikolaidou, S., Lambropoulou, M., Alexiadis, G., Manavis, J. & Papadopoulos, N. (2005) Primary gastric Hodgkin's lymphoma: a case report and review of the literature. Leukemia & Lymphoma, 46, 147-150.
123. Wirth, A., Teo, A., Wittwer, H., MacManus, M. & Ryan, G. (1999) Gastric irradiation for MALT lymphoma: reducing the target volume, fast!. Australasian Radiology, 43, 87-90.
124. Witzig, T.E., Gordon, L.I., Emmnouilides, C., Wiseman, G.A., Dimitrov, G., Ding, E., Lee, D.D. & White, C.A. (2001) Safety and efficacy of Zevalin in four patients with mucosa associated lymphoid tissue (MALT) lymphoma' (abstract). Blood, 98, 254b.
125. Witzig, T.E., Flinn, I.W. & Gordon, L.I. (2002) Randomized controlled trial of Yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma. Journal of Clinical Oncology, 20, 2453-2463.
126. Wohrer, S., Drach, J., Hejna, M., Scheithauer, W., Dirisamer, A., Puspok, A., Chott, A. & Raderer, M. (2003) Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Annals of Oncology, 14, 1758-1761.
127. Wotherspoon, A.C. & Savio, A. (2004) Molecular follow-up in gastric MALT lymhomas'. In: MALT Lymphomas (ed. by E. Zucca), pp. 91-98. Landes Bioscience/Kluwer Academic, Georgetown, TX.
128. Wotherspoon, A.C., Ortiz-Hidalgo, C., Falzon, M.R. & Isaacson, P.G. (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet, 338, 1175-1176.
129. Wotherspoon, A.C., Doglioni, C. & Isaacson, P.G. (1992) Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology, 20, 29-34.
130. Wotherspoon, A.C., Doglioni, C., Diss, T.C., Pan, L., Moschini, A., De Boni, M. & Isaacson, P.G. (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet, 342, 575-577.
131. Yahalom, J. (2001) MALT lymphomas: a radiation oncology viewpoint. Annals of Hematology, 80 (Suppl. 3), B100-B105.
132. Ye, H., Liu, H., Attygalle, A., Wotherspoon, A.C., Nicholson, A.G., Charlotte, F., Leblond, V., Speight, P., Goodlad, J., Lavergne-Slove, A., Martin-Subero, J.I., Siebert, R., Dogan, A., Isaacson, P.G. & Du, M.Q. (2003) Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood, 102, 1012-1018.
133. Yoon, S.S., Coit, D.G., Portlock, C.S. & Karpeh, M.S. (2004) The diminishing role of surgery in the treatment of gastric lymphoma. Annals of Surgery, 240, 28-37.
134. Zinzani, P.L., Stefoni, V., Musuraca, G., Tani, M., Alinari, L., Gabriele, A., Marchi, E., Pileri, S. & Baccarani, M. (2004) Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer, 100, 2190-2194.
135. Zucca, E. & Bertoni, F. (2005) Another Piece of the MALT Lymphomas Jigsaw. Journal of Clinical Oncology, 23, 4832-4834.
136. Zucca, E. & Cavalli, F. (2004) Are antibiotics the treatment of choice for gastric lymphoma? Current Hematology Reports, 3, 11-16.
137. Zucca, E., Roggero, E., Bertoni, F. & Cavalli, F. (1997) Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas. Annals of Oncology, 8, 727-737.
138. Zucca, E., Roggero, E. & Pileri, S. (1998a) B-cell lymphoma of MALT type: a review with special emphasis on diagnostic and management problems of low-grade gastric tumours. British Journal of Haematology, 100, 3-14.
139. Zucca, E., Bertoni, F., Roggero, E., Bosshard, G., Cazzaniga, G., Pedrinis, E., Biondi, A. & Cavalli, F. (1998b) Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. New England Journal of Medicine, 338, 804-810.
140. Zucca, E., Roggero, E., Bertoni, F., Conconi, A. & Cavalli, F. (1999) Primary extranodal non-Hodgkin's lymphomas. Part 2: head and neck, central nervous system and other less common sites. Annals of Oncology, 10, 1023-1033.
141. Zucca, E., Bertoni, F., Roggero, E. & Cavalli, F. (2000) The gastric marginal zone B-cell lymphoma of MALT type. Blood, 96, 410-419.
142. Zucca, E., Conconi, A. & Cavalli, F. (2002) Treatment of extranodal lymphomas. Best Practice & Research Clinical Haematology, 15, 533-547.